CAR-T Therapy for Solid Tumors – Now Possible! 🩺 New Kidney Cancer Treatment [Video]

Precision Oncology specialist, Alex Rolland, discusses how CAR-T technology is now possible for solid tumors – and how this can benefit patients, including those with kidney cancer.

In the past, CAR-T technology has been very effective for Lymphomas but not effective in solid tumors. Fortunately, new developments have occurred and CAR-T therapy is now able to work for solid tumors!

Alex explains the results of a study that shows how CAR-T technology has developed to the point of working for solid tumors and what this means for patients and their treatment teams.

He is joined by Precision Oncology Advocate and CTOAM cofounder, Michelle Morand. They share the key takeaways that patients need to know about CAR-T for solid tumors – including next steps you can take to find out if it will work for you and how to access it.

00:00 Introduction
00:16 Alex’s Presentation: CAR-T Therapy for Solid Tumors – The Time has Come for Kidney Cancers
01:20 What is CAR-T cell Therapy?
03:14 What is CART-T cell Therapy for Lymphomas (B-cells)?
04:28 New advancement: CAR-T for Solid Tumors
05:44 Exploring the phase 1 COBALT-RCC study
06:55 Understanding the CD70 Normal Mechanism vs. CD70 Cancer Mechanism
09:35 Visual graphic illustrating CTX130 Construct
10:33 Exploring the results of the COBALT-RCC trial
12:40 How to get the information and support you need now

If you’d like to identify the most effective treatment for your cancer, and how to access it as soon as possible (and through your current treatment team) reach out to us and book a free 30-min consult using the link below 👇

Book a Free Session With Alex And His Precision Oncology Team: https://www.ctoam.com/free-strategy-session

Download CTOAM’S Free Ebook Here: https://www.ctoam.com/ebook/

Join our (free) “Cancer Just the Facts” online program!
👉 https://cancerjustthefacts.com/
Get hundreds of free resources on Precision Cancer Medicine and access to our weekly Zoom calls with cancer experts.

–

CTOAM is a worldwide, Canadian-based personalized cancer care and precision oncology service specializing in getting our client’s rapid access to the best possible cancer treatment available for their form of cancer, while assisting their physicians in having the most current data from which to make confident treatment decisions on your behalf.

We facilitate access to peer-reviewed, science-based precision diagnostics such as PET/CT scans, liquid biopsy (blood-based genetic tests) and detailed genetic panels. We use these leading diagnostic tools, combined with a thorough and personalized research review, as our team explores the most advanced scientific data available today to find the best options for you.

Other ways to stay in touch with CTOAM:

Facebook: https://www.facebook.com/CancerTreatmentOptionsandManagement/
LinkedIn: https://www.linkedin.com/company/ctoam
Twitter: https://twitter.com/CTOAM
Blog: https://research.ctoam.com/

LinkedIn (Liquid Biopsy Labs): https://www.linkedin.com/company/13063544
LBL Twitter: https://twitter.com/LiquidBiopsyNow

Disclaimer:

Please understand that these videos are meant for educational purposes only. These videos are not intended to diagnose or be used as treatment advice. Viewers are encouraged to speak with their doctor or healthcare professionals for medical advice and before making any changes to their healthcare based on this information. All statements made in this video regarding medical treatments and health conditions are sourced and have been approved by the U.S. Food and Drug Administration (FDA). Watching this video is not a substitute for professional medical advice or a diagnosis.